FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297460416> ?p ?o ?g. }

• W4297460416 endingPage "096032712211264" @default.
• W4297460416 startingPage "096032712211264" @default.
• W4297460416 abstract "The present study was designed to investigate the antidiabetic effect of nerolidol on high-fat diet and streptozotocin-induced diabetic rats. Type 2 diabetes was induced in animals by feeding them a high-fat diet for 4 weeks and administering a single intraperitoneal dose of streptozotocin (35 mg/kg body weight). Diabetic rats were treated with nerolidol (25 mg/kg BW) for 28 days. Results showed that nerolidol treatment significantly reduced (p < 0.05) the level of elevated glucose, glycosylated hemoglobin and improved (p < 0.05) the body weight and insulin level. Nerolidol also considerably improved (p < 0.05) the carbohydrate metabolic enzyme activities and increased the glycogen storage in the liver of diabetic rats. Increased serum triglycerides, total cholesterol (C), low-density lipoproteins-C and very low-density lipoproteins-C levels were significantly lowered (p < 0.05), while reduction of serum high-density lipoprotein-C was alleviated after administration of nerolidol. In addition, nerolidol attenuated oxidative stress markers by significantly increasing (p < 0.05) the levels of superoxide dismutase, catalase, reduced glutathione, and lowering (p < 0.05) the level of thiobarbituric acid reactive substances, and lipid hydroperoxide. Similarly, nerolidol showed its pharmacological effects against hepatic markers via restoring (p < 0.05) the alleviated level of alanine transaminase, aspartate aminotransferase, and alkaline phosphatase. Finally, it improved insulin-dependent glucose transport in skeletal muscle by enhancing and activating glucose transporter protein-4. These findings confirmed the antidiabetic potential of nerolidol in type 2 diabetic rats. This may be related to a high antioxidant capacity, the restoration of plasma insulin and lipid levels, and the activation of insulin signaling in STZ/HFD-induced diabetic rats." @default.
• W4297460416 created "2022-09-29" @default.
• W4297460416 creator A5002188808 @default.
• W4297460416 creator A5089734471 @default.
• W4297460416 date "2022-01-01" @default.
• W4297460416 modified "2023-09-30" @default.
• W4297460416 title "Antidiabetic effects of nerolidol through promoting insulin receptor signaling in high-fat diet and low dose streptozotocin-induced type 2 diabetic rats" @default.
• W4297460416 cites W1508167383 @default.
• W4297460416 cites W1809230663 @default.
• W4297460416 cites W1890305607 @default.
• W4297460416 cites W1970538359 @default.
• W4297460416 cites W1982559741 @default.
• W4297460416 cites W1994787654 @default.
• W4297460416 cites W1995382021 @default.
• W4297460416 cites W1998666012 @default.
• W4297460416 cites W2006370393 @default.
• W4297460416 cites W2038345117 @default.
• W4297460416 cites W2050315451 @default.
• W4297460416 cites W2053616715 @default.
• W4297460416 cites W2060194897 @default.
• W4297460416 cites W2060276188 @default.
• W4297460416 cites W2061333433 @default.
• W4297460416 cites W2063680724 @default.
• W4297460416 cites W2064279605 @default.
• W4297460416 cites W2075488370 @default.
• W4297460416 cites W2085673716 @default.
• W4297460416 cites W2096795975 @default.
• W4297460416 cites W2125733720 @default.
• W4297460416 cites W2296585153 @default.
• W4297460416 cites W2324331745 @default.
• W4297460416 cites W2360439189 @default.
• W4297460416 cites W2469968941 @default.
• W4297460416 cites W2470838351 @default.
• W4297460416 cites W2509220708 @default.
• W4297460416 cites W2510835175 @default.
• W4297460416 cites W2516762108 @default.
• W4297460416 cites W2756045870 @default.
• W4297460416 cites W2793318248 @default.
• W4297460416 cites W2793435470 @default.
• W4297460416 cites W2830190460 @default.
• W4297460416 cites W2885519461 @default.
• W4297460416 cites W2886442927 @default.
• W4297460416 cites W2886504687 @default.
• W4297460416 cites W2888814360 @default.
• W4297460416 cites W2921967571 @default.
• W4297460416 cites W2956532356 @default.
• W4297460416 cites W2983229458 @default.
• W4297460416 cites W2984149348 @default.
• W4297460416 cites W3009785233 @default.
• W4297460416 cites W3048111654 @default.
• W4297460416 cites W3081584251 @default.
• W4297460416 cites W3081655479 @default.
• W4297460416 cites W3104759742 @default.
• W4297460416 cites W3108820287 @default.
• W4297460416 cites W3173811337 @default.
• W4297460416 cites W3176732961 @default.
• W4297460416 cites W3196213304 @default.
• W4297460416 cites W4213464763 @default.
• W4297460416 doi "https://doi.org/10.1177/09603271221126487" @default.
• W4297460416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36169646" @default.
• W4297460416 hasPublicationYear "2022" @default.
• W4297460416 type Work @default.
• W4297460416 citedByCount "2" @default.
• W4297460416 countsByYear W42974604162023 @default.
• W4297460416 crossrefType "journal-article" @default.
• W4297460416 hasAuthorship W4297460416A5002188808 @default.
• W4297460416 hasAuthorship W4297460416A5089734471 @default.
• W4297460416 hasBestOaLocation W42974604161 @default.
• W4297460416 hasConcept C126322002 @default.
• W4297460416 hasConcept C134018914 @default.
• W4297460416 hasConcept C160160445 @default.
• W4297460416 hasConcept C181199279 @default.
• W4297460416 hasConcept C185592680 @default.
• W4297460416 hasConcept C2775838275 @default.
• W4297460416 hasConcept C2776151105 @default.
• W4297460416 hasConcept C2777278459 @default.
• W4297460416 hasConcept C2777499176 @default.
• W4297460416 hasConcept C2778606649 @default.
• W4297460416 hasConcept C2778905741 @default.
• W4297460416 hasConcept C2779280383 @default.
• W4297460416 hasConcept C2779306644 @default.
• W4297460416 hasConcept C2779679107 @default.
• W4297460416 hasConcept C2779729912 @default.
• W4297460416 hasConcept C31903555 @default.
• W4297460416 hasConcept C55493867 @default.
• W4297460416 hasConcept C555293320 @default.
• W4297460416 hasConcept C71924100 @default.
• W4297460416 hasConceptScore W4297460416C126322002 @default.
• W4297460416 hasConceptScore W4297460416C134018914 @default.
• W4297460416 hasConceptScore W4297460416C160160445 @default.
• W4297460416 hasConceptScore W4297460416C181199279 @default.
• W4297460416 hasConceptScore W4297460416C185592680 @default.
• W4297460416 hasConceptScore W4297460416C2775838275 @default.
• W4297460416 hasConceptScore W4297460416C2776151105 @default.
• W4297460416 hasConceptScore W4297460416C2777278459 @default.
• W4297460416 hasConceptScore W4297460416C2777499176 @default.
• W4297460416 hasConceptScore W4297460416C2778606649 @default.
• W4297460416 hasConceptScore W4297460416C2778905741 @default.

• next